2-[(3S)-3-aminopiperidin-1-yl]-4-[(2-cyclopentyl-6-propan-2-ylpiperidin-4-yl)amino]-1,3-diazinane-5-carboxamide

C23H45N7O — CID 162462821

IUPAC2-[(3S)-3-aminopiperidin-1-yl]-4-[(2-cyclopentyl-6-propan-2-ylpiperidin-4-yl)amino]-1,3-diazinane-5-carboxamide
SMILESCC(C)C1CC(NC2NC(N3CCC[C@H](N)C3)NCC2C(N)=O)CC(C2CCCC2)N1
InChIInChI=1S/C23H45N7O/c1-14(2)19-10-17(11-20(28-19)15-6-3-4-7-15)27-22-18(21(25)31)12-26-23(29-22)30-9-5-8-16(24)13-30/h14-20,22-23,26-29H,3-13,24H2,1-2H3,(H2,25,31)/t16-,17?,18?,19?,20?,22?,23?/m0/s1
InChIKeyCPHYZTYROMPNDD-SATILHMASA-N
MW435.66 g/mol
LogP0.24
Rot. Bonds6

About 2-[(3S)-3-aminopiperidin-1-yl]-4-[(2-cyclopentyl-6-propan-2-ylpiperidin-4-yl)amino]-1,3-diazinane-5-carboxamide

2-[(3S)-3-aminopiperidin-1-yl]-4-[(2-cyclopentyl-6-propan-2-ylpiperidin-4-yl)amino]-1,3-diazinane-5-carboxamide (PubChem CID 162462821) has the molecular formula C23H45N7O and a molecular weight of 435.66 g/mol. Its IUPAC name is 2-[(3S)-3-aminopiperidin-1-yl]-4-[(2-cyclopentyl-6-propan-2-ylpiperidin-4-yl)amino]-1,3-diazinane-5-carboxamide.

Molecular Properties

Compound Name2-[(3S)-3-aminopiperidin-1-yl]-4-[(2-cyclopentyl-6-propan-2-ylpiperidin-4-yl)amino]-1,3-diazinane-5-carboxamide
PubChem CID162462821
Molecular FormulaC23H45N7O
Molecular Weight435.66 g/mol
Exact Mass435.37
IUPAC Name2-[(3S)-3-aminopiperidin-1-yl]-4-[(2-cyclopentyl-6-propan-2-ylpiperidin-4-yl)amino]-1,3-diazinane-5-carboxamide
SMILESCC(C)C1CC(NC2NC(N3CCC[C@H](N)C3)NCC2C(N)=O)CC(C2CCCC2)N1
InChIInChI=1S/C23H45N7O/c1-14(2)19-10-17(11-20(28-19)15-6-3-4-7-15)27-22-18(21(25)31)12-26-23(29-22)30-9-5-8-16(24)13-30/h14-20,22-23,26-29H,3-13,24H2,1-2H3,(H2,25,31)/t16-,17?,18?,19?,20?,22?,23?/m0/s1
InChIKeyCPHYZTYROMPNDD-SATILHMASA-N
XLogP0.24
TPSA120.47 Ų
H-Bond Donors6
H-Bond Acceptors7
Rotatable Bonds6
Heavy Atoms31
Complexity

Lipinski Rule of Five

1 violation

RuleValue
MW ≤ 500435.66
LogP ≤ 50.24
H-Bond Donors ≤ 56
H-Bond Acceptors ≤ 107

Analyze 2-[(3S)-3-aminopiperidin-1-yl]-4-[(2-cyclopentyl-6-propan-2-ylpiperidin-4-yl)amino]-1,3-diazinane-5-carboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 2-[(3S)-3-aminopiperidin-1-yl]-4-[(2-cyclopentyl-6-propan-2-ylpiperidin-4-yl)amino]-1,3-diazinane-5-carboxamide?
The IUPAC name of 2-[(3S)-3-aminopiperidin-1-yl]-4-[(2-cyclopentyl-6-propan-2-ylpiperidin-4-yl)amino]-1,3-diazinane-5-carboxamide (CID 162462821) is 2-[(3S)-3-aminopiperidin-1-yl]-4-[(2-cyclopentyl-6-propan-2-ylpiperidin-4-yl)amino]-1,3-diazinane-5-carboxamide.
What is the SMILES notation for 2-[(3S)-3-aminopiperidin-1-yl]-4-[(2-cyclopentyl-6-propan-2-ylpiperidin-4-yl)amino]-1,3-diazinane-5-carboxamide?
The canonical SMILES for 2-[(3S)-3-aminopiperidin-1-yl]-4-[(2-cyclopentyl-6-propan-2-ylpiperidin-4-yl)amino]-1,3-diazinane-5-carboxamide is CC(C)C1CC(NC2NC(N3CCC[C@H](N)C3)NCC2C(N)=O)CC(C2CCCC2)N1.
What is the InChIKey of 2-[(3S)-3-aminopiperidin-1-yl]-4-[(2-cyclopentyl-6-propan-2-ylpiperidin-4-yl)amino]-1,3-diazinane-5-carboxamide?
The InChIKey is CPHYZTYROMPNDD-SATILHMASA-N. The full InChI is InChI=1S/C23H45N7O/c1-14(2)19-10-17(11-20(28-19)15-6-3-4-7-15)27-22-18(21(25)31)12-26-23(29-22)30-9-5-8-16(24)13-30/h14-20,22-23,26-29H,3-13,24H2,1-2H3,(H2,25,31)/t16-,17?,18?,19?,20?,22?,23?/m0/s1.
What are the key properties of 2-[(3S)-3-aminopiperidin-1-yl]-4-[(2-cyclopentyl-6-propan-2-ylpiperidin-4-yl)amino]-1,3-diazinane-5-carboxamide?
2-[(3S)-3-aminopiperidin-1-yl]-4-[(2-cyclopentyl-6-propan-2-ylpiperidin-4-yl)amino]-1,3-diazinane-5-carboxamide has a molecular weight of 435.66 g/mol, XLogP of 0.24, 6 rotatable bonds, 6 hydrogen bond donors, and 7 hydrogen bond acceptors.
Where does this data come from?
All data for 2-[(3S)-3-aminopiperidin-1-yl]-4-[(2-cyclopentyl-6-propan-2-ylpiperidin-4-yl)amino]-1,3-diazinane-5-carboxamide is sourced from PubChem (CID 162462821), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).